Bachelor of Arts in Economics, University of California, San Diego (UCSD)

Member of the Inaugural Cohort of Young Investors of H50 (China Healthcare Investment H50)
2023 Forbes China · Top 100 Young Returnee Elites
2025 Fortune China · 40 Under 40 – Most Promising Business Elites
Consecutive Honoree, U40 Young Elite List
40 Under 40 – Best Direct Investment Fund Young Investors
2022 Supernova · Top 50
Young Investor in Healthcare

Initiated and deeply participated in investments in star projects including OBiO Technology, Asieris Pharmaceuticals, Insight Lifetech, and Harbour BioMed

Previously served in the Asset Management Department of China International Capital Corporation (CICC)